Impaired IFN-α secretion by plasmacytoid dendritic cells induced by TLR9 activation in chronic idiopathic urticaria

British Journal of Dermatology

Volumn 164, Issue 6, 2011, Pages 1271-1279

  Futata, E ^a   Azor, M ^a   Dos Santos, J ^a   Maruta, C ^b   Sotto, M ^b   Guedes, F ^b   Rivitti, E ^b   Duarte, A ^b   Sato, M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Dermatological Outpatient Clinic   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CPG OLIGODEOXYNUCLEOTIDE; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; STAT1 PROTEIN; STAT4 PROTEIN; TOLL LIKE RECEPTOR 9;

ADULT; AGED; ARTICLE; CHRONIC URTICARIA; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ADULT; AGED; CHRONIC DISEASE; DENDRITIC CELLS; DOWN-REGULATION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNITY, INNATE; IMMUNOHISTOCHEMISTRY; INTERFERON-ALPHA; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; OLIGODEOXYRIBONUCLEOTIDES; PHOSPHORYLATION; STAT1 TRANSCRIPTION FACTOR; STAT4 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTOR 9; URTICARIA; YOUNG ADULT;

EID: 79957619160     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.10198.x     Document Type: Article

References (45)

1. O'Doherty U, Peng M, Gezelter S, et al. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 1994; 82: 487-93. (Pubitemid 24251635)
2. Robinson SP, Patterson S, English N, et al. Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol 1999; 29: 2769-78. (Pubitemid 30099001)
3. Colonna M, Trinchieri G, Liu YJ,. Plasmacytoid dendritic cells in immunity. Nat Immunol 2004; 5: 1219-26. (Pubitemid 41057736)
4. Bauer S, Kirschning CJ, Hacker H, et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci U S A 2001; 98: 9237-42. (Pubitemid 32743900)
5. Hartmann G, Battiany J, Poeck H, et al. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells. Eur J Immunol 2003; 33: 1633-41. (Pubitemid 36790424)
6. Kawai T, Akira S,. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11: 373-84.
7. Conrad C, Meller S, Gilliet M,. Plasmacytoid dendritic cells in the skin: to sense or not to sense nucleic acids. Semin Immunol 2009; 21: 101-9.
8. Duramad O, Fearon KL, Chang B, et al. Inhibitors of TLR-9 act on multiple cell subsets in mouse and man in vitro and prevent death in vivo from systemic inflammation. J Immunol 2005; 174: 5193-200. (Pubitemid 40593156)
9. Lenert P,. Inhibitory oligodeoxynucleotides-therapeutic promise for systemic autoimmune diseases? Clin Exp Immunol 2005; 140: 1-10. (Pubitemid 40461067)
10. Klinman DM, Zeuner R, Yamada H, et al. Regulation of CpG-induced immune activation by suppressive oligodeoxynucleotides. Ann N Y Acad Sci 2003; 1002: 112-23. (Pubitemid 38253336)
11. Sozzani S,. Dendritic cell trafficking: more than just chemokines. Cytokine Growth Factor Rev 2005; 16: 581-92. (Pubitemid 41505518)
12. Banchereau J, Pascual V,. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 2006; 25: 383-92. (Pubitemid 44354221)
13. Kaplan AP,. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol 2004; 114: 465-74. (Pubitemid 39194914)
14. Kaplan AP, Greaves M,. Pathogenesis of chronic urticaria. Clin Exp Allergy 2009; 39: 777-87.
15. Hide M, Francis DM, Grattan CE, et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993; 328: 1599-604. (Pubitemid 23151920)
16. Grattan CE,. Basophils in chronic urticaria. J Investig Dermatol Symp Proc 2001; 6: 139-40. (Pubitemid 33758589)
17. Lourenco FD, Azor MH, Santos JC, et al. Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus. Br J Dermatol 2008; 158: 979-86. (Pubitemid 351521459)
18. Kaplan A,. Inflammation in chronic urticaria is not limited to the consequences of mast cell (or basophil) degranulation. Clin Exp Allergy 2010; 40: 834-5.
19. Tedeschi A, Asero R, Lorini M, et al. Plasma levels of matrix metalloproteinase-9 in chronic urticaria patients correlate with disease severity and C-reactive protein but not with circulating histamine-releasing factors. Clin Exp Allergy 2010; 40: 875-81.
20. Caproni M, Cardinali C, Giomi B, et al. Serological detection of eotaxin, IL-4, IL-13, IFN-gamma, MIP-1alpha, TARC and IP-10 in chronic autoimmune urticaria and chronic idiopathic urticaria. J Dermatol Sci 2004; 36: 57-9. (Pubitemid 39370026)
21. Tedeschi A, Lorini M, Suli C, et al. Serum interleukin-18 in patients with chronic ordinary urticaria: association with disease activity. Clin Exp Dermatol 2007; 32: 568-70. (Pubitemid 47231136)
22. Ciprandi G, De Amici M, Berardi L, et al. Serum neopterin levels in spontaneous urticaria and atopic dermatitis. Clin Exp Dermatol 2011; 36: 85-7.
23. Dos Santos JC, Azor MH, Nojima VY, et al. Increased circulating pro-inflammatory cytokines and imbalanced regulatory T-cell cytokines production in chronic idiopathic urticaria. Int Immunopharmacol 2008; 8: 1433-40.
24. Livak KJ, Schmittgen TD,. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-8. (Pubitemid 34164012)
25. Sinigaglia F, D'Ambrosio D, Rogge L,. Type I interferons and the Th1/Th2 paradigm. Dev Comp Immunol 1999; 23: 657-63. (Pubitemid 29509755)
26. Lankford CS, Frucht DM,. A unique role for IL-23 in promoting cellular immunity. J Leukoc Biol 2003; 73: 49-56. (Pubitemid 36125674)
27. Shrestha S, Wershil B, Sarwark JF, et al. Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells. Arthritis Rheum 2010; 62: 2813-22.
28. Albanesi C, Scarponi C, Bosisio D, et al. Immune functions and recruitment of plasmacytoid dendritic cells in psoriasis. Autoimmunity 2010; 43: 215-19.
29. Krug A, Rothenfusser S, Hornung V, et al. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur J Immunol 2001; 31: 2154-63. (Pubitemid 32640732)
30. Horr B, Borck H, Diel J, et al. The role of the histamine H(4) receptor in signal transduction of atopic and non-atopic human lymphocytes ex vivo. Inflamm Res 2006; 55 (Suppl. 1): S53-4. (Pubitemid 43760590)
31. McKenna K, Beignon AS, Bhardwaj N,. Plasmacytoid dendritic cells: linking innate and adaptive immunity. J Virol 2005; 79: 17-27. (Pubitemid 39648359)
32. Vermi W, Lonardi S, Morassi M, et al. Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage. Immunobiology 2009; 214: 877-86.
33. Wollenberg A, Wagner M, Gunther S, et al. Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J Invest Dermatol 2002; 119: 1096-102. (Pubitemid 35434173)
34. Albanesi C, Scarponi C, Pallotta S, et al. Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J Exp Med 2009; 206: 249-58.
35. Zawar V, Godse K, Sankalecha S,. Chronic urticaria associated with recurrent genital herpes simplex infection and success of antiviral therapy-a report of two cases. Int J Infect Dis 2010; 14: e514-17.
36. Vuorinen T, Lammintausta K, Kotilainen P, et al. Presence of parvovirus B19 DNA in chronic urticaric and healthy human skin. J Clin Virol 2002; 25: 217-21. (Pubitemid 35287247)
37. Gilliet M, Cao W, Liu YJ,. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 2008; 8: 594-606.
38. Peng WM, Yu CF, Allam JP, et al. Inhibitory oligodeoxynucleotides downregulate herpes simplex virus-induced plasmacytoid dendritic cell type I interferon production and modulate cell function. Hum Immunol 2007; 68: 879-87.
39. Shirota H, Gursel I, Gursel M, et al. Suppressive oligodeoxynucleotides protect mice from lethal endotoxic shock. J Immunol 2005; 174: 4579-83.
40. Schroeder JT, Bieneman AP, Xiao H, et al. TLR9- and FcepsilonRI-mediated responses oppose one another in plasmacytoid dendritic cells by down-regulating receptor expression. J Immunol 2005; 175: 5724-31. (Pubitemid 41508055)
41. Tversky JR, Le TV, Bieneman AP, et al. Human blood dendritic cells from allergic subjects have impaired capacity to produce interferon-alpha via Toll-like receptor 9. Clin Exp Allergy 2008; 38: 781-8. (Pubitemid 351550669)
42. Dzionek A, Sohma Y, Nagafune J, et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med 2001; 194: 1823-34. (Pubitemid 34028661)
43. Cao W, Rosen DB, Ito T, et al. Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production. J Exp Med 2006; 203: 1399-405. (Pubitemid 43877601)
44. Fuchs A, Cella M, Kondo T, et al. Paradoxic inhibition of human natural interferon-producing cells by the activating receptor NKp44. Blood 2005; 106: 2076-82. (Pubitemid 41291722)
45. Mazzoni A, Leifer CA, Mullen GE, et al. Cutting edge: histamine inhibits IFN-alpha release from plasmacytoid dendritic cells. J Immunol 2003; 170: 2269-73. (Pubitemid 36245610)